COMMUNIQUÉS West-GlobeNewswire

NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight
22/10/2026
DENVER, Oct. 22, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) — NeOnc Technologies Holdings (NASDAQ: NTHI) is taking its brain cancer research story to a national television audience at a moment when several [...]
Claritas and Qubiotech join forces to build an independent challenger in quantitative PET — from whole body to brain
22/10/2026
LONDON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd., a subsidiary of Claritas HealthTech Ltd, today announced that the Claritas group has signed heads of terms to acquire a majority stake in [...]
Beacon Biosignals Acquires Snap Diagnostics, Paving the Way for EEG-Enabled Home Sleep Testing in Every Care Setting
22/10/2026
Acquisition more than doubles Beacon’s patient reach, creating a national channel to bring EEG-enabled home sleep testing to primary care, telehealth, psychiatry, and other specialty providers starting in 2027 BOSTON, [...]
Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
22/10/2026
Data from ongoing study supports the potential clinical utility of whole-genome sequencing-based Precise MRD™ to identify recurrence risk and detect disease earlier following surgery SALT LAKE CITY, Oct. 22, 2026 (GLOBE [...]
FEM By UPSA Appoints U.S. Advisors to Advance Science-Backed, Non-Hormonal Menopause Support
22/10/2026
Menopause and pharmacy experts join FEM’s mission to bring greater scientific rigor and evidence-led education to midlife women’s health RUEIL-MALMAISON, France, Oct. 22, 2026 (GLOBE NEWSWIRE) -- FEM By UPSA , a global [...]
New Study Finds Pycnogenol® Improves Quality of Life and Symptoms Associated with Osteopenia and Osteoporosis in Post-Menopausal Women
22/10/2026
Vitality, physical comfort and markers of bone resorption improved among participants taking Pycnogenol® Key Takeaways Pycnogenol ® , a natural extract from French maritime pine bark, was studied as a dietary supplement [...]
Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026
22/10/2026
STOUGHTON, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood [...]
Replimune to Report the Fiscal Second Quarter 2027 Financial Results and Provide Corporate Update on October 28, 2026
22/10/2026
WOBURN, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a commercial stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that it will [...]
AskBio Announces 5 Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress
22/10/2026
Durham, N.C., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Five poster presentations will highlight exciting progress in AskBio’s adeno-associated virus (AAV) manufacturing technologies AskBio Inc. (AskBio), a gene therapy company [...]
MIRA Pharmaceuticals Reports MIRA-55 Demonstrated Significant Pain Relief Comparable to Celebrex in Chronic Inflammatory Pain Study
22/10/2026
Positive IND-Enabling Proof-of-Concept Study Demonstrates Sustained Efficacy Without Observed Tolerance, Reduced Inflammation-Associated Swelling, and Favorable Tolerability MIAMI, Oct. 22, 2026 (GLOBE NEWSWIRE) -- MIRA [...]
Krystal Biotech to Report Third Quarter 2026 Financial Results on November 2, 2026
22/10/2026
PITTSBURGH, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that it will report its third quarter 2026 financial results on Monday, November 2, 2026, prior to the [...]
ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2026
22/10/2026
Seven abstracts spanning CKD translational model studies and drug product characterization provide converging evidence supporting a multifactorial mechanism of action for rilparencel One clinical abstract presents a new [...]
Verrica Pharmaceuticals Announces Achievement of Milestones Unlocking Access to the Full $27.5 Million of Non-Dilutive Growth Capital Under Credit Facility
22/10/2026
– Company’s achievement of pre-defined revenue, growth and operational milestones increases facility commitment by $15.0 million – – Capital now available to support continued growth of the YCANTH® business and [...]
Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse
22/10/2026
In naturally aged mice treated from 80 weeks of age and followed until natural death, once-weekly PTC-2105 (25 mg/kg) significantly increased overall survival versus saline (log-rank p = 0.0142) “Speedy,” a PTC-2105- [...]
LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
22/10/2026
SAN DIEGO, Oct. 22, 2026 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ ® (aceclidine ophthalmologic solution) 1. [...]
Celularity Regains Compliance with Nasdaq Periodic Reporting Requirement
22/10/2026
Nasdaq closes reporting deficiency following filing of second-quarter 2026 Form 10-Q FLORHAM PARK, N.J., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative [...]
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
22/10/2026
GERMANTOWN, Md., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose [...]
Ignite Proteomics Enters Breast Cancer Research Collaboration with Leading Cancer Center
22/10/2026
Research Will Apply Ignite's RPPA-Based Proteomic Test to Study Treatment Response and Resistance GOLDEN, Colo., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Ignite Proteomics, Inc. (“Ignite” or the “Company”), a precision [...]
Annovis to Attend the CTAD 2026 with Three Presentations
22/10/2026
MALVERN, Pa., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum